AstraZeneca PLC
1320.00
08-5月-25 11:29:51
15 分の遅延
株式
-25.50
-1.90%
本日の幅
1303.50 - 1345.00
ISIN
N/A
ソース
NASD.OMX SE
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 6 2024 10:33:02 提供 NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 6 2024 03:08:02 提供 NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 6 2024 03:15:21 提供 NASDAQ US Markets
-
AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial
16 6 2024 12:33:03 提供 NASDAQ US Markets
-
FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes
12 6 2024 21:53:19 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
10 6 2024 03:21:31 提供 NetDania Notify
-
1 Biopharma Stock Setting the New Standard in Cancer Care Drugs
07 6 2024 12:13:02 提供 NASDAQ Stocks
-
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
05 6 2024 19:29:29 提供 Forbes - World
-
AstraZeneca Completes Acquisition Of Fusion Pharma
05 6 2024 03:08:45 提供 NASDAQ US Markets
-
CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer
03 6 2024 03:15:45 提供 NASDAQ US Markets
-
Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris
30 5 2024 05:59:20 提供 NASDAQ US Markets
-
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
29 5 2024 10:20:48 提供 NASDAQ US Markets
-
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
29 5 2024 08:32:19 提供 NASDAQ US Markets
-
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
27 5 2024 02:59:14 提供 NASDAQ US Markets
-
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
24 5 2024 10:30:58 提供 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
23 5 2024 10:35:27 提供 NetDania Notify
-
AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines
21 5 2024 03:02:29 提供 NASDAQ US Markets
-
AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
20 5 2024 02:42:36 提供 NASDAQ US Markets
-
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
19 5 2024 22:05:22 提供 NASDAQ US Markets
-
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
16 5 2024 03:51:29 提供 NASDAQ US Markets